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Introduction 
The field of psychodermatology was born out of the 
intersection of dermatology and psychiatry. Its  
existence is not only a testament to the complex 
interplay between the two disciplines but a reminder 
to consider the associated psychiatric or 
dermatologic sequelae when making a primary 
diagnosis. Among the many psychocutaneous 
disorders seen by dermatologists, one that is not 
often described is the situation in which a patient 
presents with a minor, treatable skin disorder that 
the patient perceives as severe or incurable. To our 
knowledge, there is no mention in the literature of 
this clinical presentation or an associated diagnosis. 
In this review, we present a case of one such patient 
and propose the need for a new subcategory of 
psychocutaneous disorders, named delusion 
inversus, to classify these patients. 
There is no universally-accepted classification 
system for psychocutaneous disorders. However, the 
most widely-published classification system 
described by Koo and Lee organizes the conditions 
into 4 categories: psychophysiologic disorders (e.g. 
psoriasis, rosacea), psychiatric disorders with 
dermatologic symptoms (e.g. trichotillomania, 
delusions of parasitosis), dermatologic disorders 
with psychiatric sequelae (e.g. vitiligo, alopecia 
areata), and miscellaneous (e.g. cutaneous sensory 
syndromes, medication side effects), [1, 2]. 
One particular subtype of the psychiatric disorder 
with dermatologic symptoms is known as delusional 
disorder, somatic type. Delusional disorder is 
characterized by the presence of one or more 
delusions that persist for at least one month. The 
somatic type is defined by a single, discrete delusion 
of medical illness [3]. Typically patients will present 
with one of three types of discrete delusions: 
bromosis (belief that one is emitting a bad body 
odor), dysmorphosis (belief that one has a defect in a 
Abstract 
The interplay between psychiatric and dermatologic 
conditions has been recognized for decades as 
evidenced by the widely accepted classification 
system of psychocutaneous disorders: (1) primary 
dermatologic disorder with psychiatric sequelae, (2) 
primary dermatologic disorder exacerbated by stress, 
(3) primary psychiatric disorder with dermatologic 
sequelae, and (4) miscellaneous. However, there is 
minimal literature regarding dermatologic patients 
who demonstrate a preoccupation with a more 
severe cutaneous disorder despite evidence 
confirming a diagnosis of a minor, treatable skin 
condition. These patients are a hybrid of the first and 
fourth categories and should be classified under a 
new entity known as delusion inversus. These 
patients have a primary dermatologic condition; 
however, they believe their condition to be more 
severe and malignant than it is, despite evidence to 
the contrary. Their beliefs are pathological and 
analogous to delusion disorder somatic type. Given 
the scarcity of data concerning delusion inversus, the 
epidemiology, diagnosis, and management of the 
disorder as described in this review is extrapolated 
from reported cases of delusion disorder and 
delusion disorder somatic-type. Often these patients 
will present to a non-psychiatric, outpatient clinic for 
medical care. Thus, it is imperative that 
dermatologists are able to identify the condition and 
manage the patient appropriately. 
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physical feature), or parasitosis (belief that the skin is 
infested with insect or other foreign body), [3]. We 
propose the addition of a new subtype of delusional 
disorder somatic type known as delusion inversus. 
Unlike typical delusional disorder somatic type, 
delusion inversus is categorized as a primary 
dermatologic condition with psychiatric sequelae 
rather than a primary psychiatric condition. 
Clinical Case 
A 64-year-old woman presented with annular scaly 
skin lesions, which had persisted for several months. 
She reported performing extensive research online 
to better understand the lesions and shared that she 
thought she had lupus erythematosus. A potassium 
hydroxide preparation showed branching hyphae 
consistent with a diagnosis of tinea corporis. Despite 
the evidence, the patient held firmly to the belief that 
she had lupus erythematosus. She refused topical 
antifungal therapy and departed the clinic without 
treatment. 
 
Discussion 
Defining delusional disorder 
There are countless clinical cases, such as this one, in 
which patients anchor to a more severe diagnosis 
often influenced by internet searches, family, friends, 
or other providers. We believe that this is consistent 
with a new subtype of delusional disorder somatic 
type — delusion inversus. Delusion inversus is 
defined as a single, sustained delusion of a grave, 
incurable dermatologic condition in the setting of a 
diagnosed, benign skin condition persisting for at 
least one month. Patients with delusion inversus 
maintain their delusion despite clinicopathological 
evidence to the contrary. Their false belief 
contradicts the information available to them and is 
incongruent with the beliefs of the larger society. 
Moreover, these patients have no previous history of 
a serious dermatologic disorder and exhibit no signs 
of disruption to social or occupational functioning. 
This brief review examines the epidemiology, clinical 
features, differential diagnosis, and treatment of 
delusional disorder and delusional disorder somatic 
type and introduces this new concept of delusion 
inversus. The results of these reported studies may 
aid in the diagnosis and management of delusion 
inversus. 
Epidemiology 
The prevalence of delusional disorder is 0.03%, 
17.4% of which are delusional disorder somatic type, 
which is estimated to be on the rise based upon 
recent epidemiological studies [4, 5]. Based on the 
literature, the condition is relatively uncommon; 
therefore, there is insufficient data to conclusively 
identify patient demographics. Gender distribution, 
for instance, is inconsistent across studies with some 
showing male predominance whereas others 
demonstrate a female predominance [5-7].  Other 
markers — age, immigration status, educational 
level, and socioeconomic status — have been more 
consistent across studies. Typically, patients present 
with delusional disorder in middle age (34 to 45 years 
old) with an estimated incidence of 20-25% in old 
age [7, 8]. Social risk factors frequently associated 
with delusional disorder include having low 
socioeconomic status, being married, being an 
immigrant, living in a city, having a family history of 
psychiatric disorders, suffering sensory deficit, and 
being exposed to stressful events [4, 9]. 
Clinical Features 
In clinical practice, patients with delusional disorder 
somatic type may present without any noticeable 
evidence of impairment. Their speech, psychomotor 
activity, and eye contact may be influenced by their 
emotional state, whereas their behavior, particularly 
their feelings and affect, are directly related to their 
delusions. It is critical that providers pay attention to 
these factors when conducting the history and 
physical examination. These patients typically 
perform well in their given occupation and may not 
demonstrate any other psychosocial limitations. All 
these factors are likely true of patients with delusion 
inversus. 
Diagnosis 
The diagnosis of delusional disorder somatic type 
and delusion inversus is based on clinical judgment 
(Table 1) [10]. Delusional disorder somatic type is a 
diagnosis of exclusion and warrants initial 
investigation for another mental disorder, substance 
or medication-induced psychosis or dermatosis, or  
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infectious process [11]. The first step is to prove a 
pathologic psychiatric condition exists. This 
necessitates keen clinical judgment to discern an 
overvalued idea from a delusion. In his report, 
Manschreck suggested evaluating the extremeness 
or inappropriateness of a patient’s behavior to help 
judge between a delusion and an overvalued idea 
[12]. The second step is to evaluate for the presence 
of associated symptoms (e.g. confusion, agitation, 
perceptual disturbances, physical symptoms, mood 
changes) and the final step is to rule out alternative 
diagnoses with a comprehensive history, mental 
status exam, and/or laboratory or radiologic studies 
[12]. 
In the case of delusion inversus, the first step is to 
diagnose the underlying skin condition based on the 
clinical and/or pathologic findings. The second step 
is to discuss the patient’s perceptions and/or fears 
related to the diagnosis. If the patient’s perceptions 
and/or fears seem exaggerated and persist despite 
evidence to the contrary, the clinician should 
consider further work up for delusion inversus. The 
final step is to prove delusion inversus exists, which 
necessitates exclusion of an underlying, pathologic 
psychiatric disorder and diagnosis of a benign skin 
condition. Delusion inversus patients will exhibit a 
singular delusion in which they perceive their  
Table 1. Diagnostic Criteria for Delusional Disorder, Somatic-type Delusional Disorder, and Delusion Inversus  
 
Diagnostic Criteria for Delusional 
Disorder 
Diagnostic Criteria for Delusional 
Disorder, Somatic Type
Diagnostic Criteria for Delusion 
Inversus 
Presence of one or more delusions with 
a duration of one month or longer 
Presence of one or more delusions with 
a duration of one month or longer 
Presence of one delusion with a 
duration of one month or longer in the 
setting of primary, benign dermatologic 
condition 
Criteria for schizophrenia have never 
been met (note: hallucinations if 
present are not prominent and are 
related to the delusional theme e.g., the 
sensation of being infected with insects 
is associated with delusions of 
infestation) 
Criteria for schizophrenia have never 
been met (note: hallucinations if 
present are not prominent and are 
related to the delusional theme e.g., the 
sensation of being infected with insects 
is associated with delusions of 
infestation) 
Criteria for schizophrenia have never 
been met (note: hallucinations if 
present are not prominent and are 
related to the delusional theme e.g., the 
sensation of being infected with insects 
is associated with delusions of 
infestation) 
Apart from the impact of the delusion(s) 
or its ramifications, functioning is not 
markedly impaired, and behavior is not 
obviously bizarre or odd 
Apart from the impact of the delusion(s) 
or its ramifications, functioning is not 
markedly impaired, and behavior is not 
obviously bizarre or odd
Apart from the impact of the delusion 
or its ramifications, functioning is not 
markedly impaired, and behavior is not 
obviously bizarre or odd
If manic or major depressive episodes 
have occurred, these have been brief 
relative to the duration of the 
delusional periods 
If manic or major depressive episodes 
have occurred, these have been brief 
relative to the duration of the 
delusional periods
If manic or major depressive episodes 
have occurred, these have been brief 
relative to the duration of the 
delusional periods 
The disturbance is not better explained 
by another mental disorder, such as 
obsessive-compulsive disorder, and is 
not due to the physiological effects of a 
substance or medication or another 
medical condition 
The disturbance is not better explained 
by another mental disorder, such as 
obsessive-compulsive disorder, and is 
not due to the physiological effects of a 
substance or medication or another 
medical condition
The disturbance is not better explained 
by another mental disorder, such as 
obsessive-compulsive disorder, and is 
not due to the physiological effects of a 
substance or medication or another 
medical condition 
Subtypes include erotomanic, 
grandiose, jealous, persecutory, mixed, 
or unspecified 
This subtype applies when the central 
theme of delusion involves bodily 
functions or sensations. Subtypes 
include bromosis, dysmorphosis, and 
parasitosis 
This subtype applies when the central 
theme of delusion involves having a 
serious dermatologic illness. This differs 
from illness anxiety disorder or somatic 
symptom disorder as patient(s) have  a. 
a diagnosed, benign dermatologic 
condition and b. are unable to 
acknowledge the possibility that their 
false belief is fictitious or exaggerated in 
spite of the evidence 
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dermatologic condition to be more serious than it is. 
These patients tend to display anxiety about their 
symptoms and will associate any changes to their 
disease severity as confirmation of their delusion. 
Lastly, these patients may or may not spend 
excessive time or energy on their health concern. 
Given that delusional disorder and delusion inversus 
are diagnoses of exclusion, clinicians must 
investigate for alternative diagnoses. Two conditions 
which are similar to delusional disorder somatic type 
are illness anxiety disorder and somatic symptom 
disorder. Illness anxiety disorder, formerly known as 
hypochondriasis, is defined as a preoccupation with 
and fear of having or acquiring a serious disorder 
persisting for at least 6 months. The patient’s 
preoccupation and fear typically arises from 
misinterpretation of non-pathologic, physical 
symptoms. These thoughts tend to pervade the 
patient’s social and occupational functioning. 
Somatic symptom disorder is an umbrella term and 
includes illness anxiety disorder as well as 
somatization disorder. Somatic symptom disorder is 
characterized by multiple, recurring physical 
complaints and associated maladaptive thoughts, 
feelings, or behaviors. Symptomatology of those 
patients with somatic symptom disorder may or may 
not accompany a medical illness. 
Patients with a history of somatic symptom disorder 
or illness anxiety disorder often complain of bodily 
distress and typically have anxiety or preoccupation 
secondary to symptoms [13]. The defining factor for 
these two conditions is the patient’s ability to 
acknowledge the possibility that their disease fears 
are exaggerated or fictitious [13]. This stands in stark 
contrast to patients with delusion inversus who are 
unable to acknowledge their beliefs may be 
exaggerated or fictitious. 
Treatment 
There is limited evidence supporting any specific 
treatment guideline in delusional disorder or 
delusional disorder somatic type as data is only 
available in the form of case studies, case series, 
retrospective reviews, prospective studies, and one 
clinical trial. The management of delusional disorder 
and delusional disorder somatic type is mainly 
pharmacologic — including antidepressants, 
anxiolytics, antipsychotics, antihistamines, and oral 
corticosteroids [14]. Second-generation 
antipsychotics (SGA) have become the mainstay of 
treatment in delusional disorder and delusional 
disorder somatic type given their side effect profile 
and efficacy as demonstrated by a nearly 50% 
positive response rate in a recent study [15]. Besides 
pharmacologic therapy, there are also 
nonpharmacologic interventions such as hypnosis, 
biofeedback, support groups, meditation, 
psychotherapy, guided imagery and progressive 
muscle relaxation, massage therapy, and cosmetic 
interventions [16]. Studies show that all subtypes of 
delusional disorder respond equally to treatment 
[15, 17]. Although prognosis is good if the condition 
is treated adequately, adherence is often challenging 
in this population and can affect treatment 
outcomes [15]. Because we are introducing delusion 
inversus as a new clinical subtype of delusional 
disorder and delusional disorder somatic type, there 
are no studies identifying effective treatment 
options. However, in a clinical setting, providers may 
utilize biopsy or laboratory results to provide 
patients with evidence of the clinical diagnosis. 
Given delusion inversus is a primary dermatologic 
condition with psychiatric sequelae, it is important 
that providers evaluate for suicidal or homicidal 
ideation. Any individuals who report suicidal or 
homicidal ideation warrant emergent referral to a 
psychiatrist for inpatient treatment or to a local 
emergency room for hospitalization [16]. Those 
patients displaying signs of severe anxiety, 
depression, or agitation warrant referral to a 
qualified mental health professional.  
Lastly, patients fitting the criteria for delusion 
inversus may benefit from timely, interdisciplinary 
care from dermatology and psychiatry practitioners. 
 
Summary 
More than 30% of dermatology patients may benefit 
from psychiatric evaluation in addition to their 
standard dermatologic care [18]. This is not an 
insignificant number given 25.3 million patient visits 
to office-based dermatologists were documented in 
one year [19]. Yet, there are significant barriers to 
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providing care in this patient population. The 
primary obstacle centers on the scarcity of research 
comparing treatment options among patients 
diagnosed with delusional disorder and delusional 
disorder somatic type. There are no randomized 
controlled trials comparing psychotropic drugs. This 
knowledge gap contributes to the deficiency in 
medical knowledge leaving clinicians unprepared to 
adequately diagnose and treat delusional disorder, 
delusional disorder somatic type, and therefore 
delusion inversus. 
The second obstacle complicating the care in this 
patient population is the tendency of the patient to 
present to non-psychiatric providers. This is further 
complicated by internet-based resources (search 
engines, discussion boards, videos, podcasts, blogs, 
online communities), which patients may use to 
better understand their condition as well as garner 
information for self-diagnosis. Internet use among 
patients with delusion inversus may prove 
detrimental and solidify patient misconceptions. 
Several studies have shown individuals with high 
health anxiety (illness anxiety disorder, somatic 
symptom disorder) as more likely to use the internet 
for health information than other resources (books, 
magazines, journals), [20, 21]. These patients often 
use search engines to look up information on 
symptoms of concern [22-25]. Yet, this is not without 
risk. In their study, White and Horvitz found that 70% 
of patients who initially search for common, non-
specific symptoms progress to searching for rare, 
more serious conditions [26]. These results suggest 
that using search engines as a diagnostic tool may  
fuel a patient’s concerns. This is a major obstacle to 
overcome, particularly in delusion inversus patients 
who may perceive their grave skin disease as the only 
issue. 
Dermatologists must consider this inflation of 
disease by the patient even after a dermatologic 
diagnosis is rendered. More importantly, providers 
should be prepared to refer patients to a psychiatrist 
for co-management. The last obstacle to consider is 
the clinical diagnosis of delusion inversus itself. 
Differentiating a delusion from an overvalued idea 
can be challenging. A patient’s personal belief may 
be misinterpreted as a delusion if his/her cultural or 
religious practices are disparate to those of the 
provider. These considerations must be considered 
when evaluating the patient for delusion inversus. 
 
Conclusion 
We advocate for the addition of delusion inversus to 
the category of psychocutaneous disorders. These 
patients commonly present to dermatologists and 
are likely to continue to do so. To adequately prepare 
for these patients, further research should be 
conducted to provide clinicians with definitive 
guidelines for care, which should include 
sociodemographic profiles, standardized screening 
tools for the outpatient setting, and an outline for 
management. 
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